Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy

NCT06957379 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

HR+/HER2- Advanced/Metastatic Breast Cancer

Interventions

DRUG: Letrozole
DRUG: Anastrozole
DRUG: Exemestane
DRUG: Fulvestrant
DRUG: Sirolimus for Injection (Albumin-bound)

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.